Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anticancer Agent 118, an N‑acylated ciprofloxacin derivative, exhibits antibacterial efficacy against Gram-positive strains and antiproliferative effects on prostate PC3 cells, making it a potential candidate for antitumor research [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 349,000 |
50 mg | 約8-10 週間 | ¥ 454,500 |
100 mg | 約8-10 週間 | ¥ 574,000 |
説明 | Anticancer Agent 118, an N‑acylated ciprofloxacin derivative, exhibits antibacterial efficacy against Gram-positive strains and antiproliferative effects on prostate PC3 cells, making it a potential candidate for antitumor research [1]. |
In vitro | Anticancer agent 118 (Compound 3) (0-100 μM; 72 hours) exhibits potent antiproliferative activity against prostate cancer PC3 cells and induces apoptosis/necrosis in these cells [1]. |
分子量 | 407.82 |
分子式 | C19H19ClFN3O4 |
CAS No. | 864443-43-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anticancer agent 118 864443-43-6 Inhibitor inhibitor inhibit